Laura White
Profiles

Laura F White, PhD

Professor, Biostatistics - Boston University School of Public Health

617-358-2519
lfwhite@bu.edu
Crosstown Center - 312
View Full Profile at BUMC

Biography

Laura Forsberg White, PhD, is a Professor of Biostatistics at Boston University and co-director of the graduate program in Biostatistics. She is the associate director of the Population Health Data Science Program and directs the Data Science and Surveillance Core of the Center for Emerging Infectious Diseases. Her research focuses on developing statistical tools to better understand the transmission dynamics and epidemiology of infectious diseases and substance use disorders. This includes the development of novel methodologies for the detection of disease outbreaks, as well as the application statistical methods for public health surveillance systems, including spatial statistics and time series. Dr. White's work includes applications and collaborations in Tuberculosis, Hepatitis C, HIV, and substance use disorders. She works with several large international studies focused on Tuberculosis, is part of the Boston Providence Center for AIDS Research, and a CDC CFA-funded Center of Excellence. She leads her own research group focused on developing statistical methods to better understand TB transmission and burden, as well as Covid-19 transmission dynamics. At SPH, she teaches Public Health Surveillance: A Methods Based Approach (BS 728).

Other Positions

  • Adjunct Assistant Professor, Biostatistics - Harvard T.H. Chan School of Public Health

Education

  • Harvard University, PhD Field of Study: Biostatistics
  • Utah State University, BS Field of Study: Mathematics
  • Harvard School of Public Health, SM/ScM Field of Study: Biostatistics

Websites

Classes Taught

  • SPHBS728

Publications

  • Published on 10/14/2024

    Overbeck V, Malatesta S, Carney T, Myers B, Parry CDH, Horsburgh CR, Theron D, White LF, Warren RM, Jacobson KR, Bouton TC. Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns. BMC Infect Dis. 2024 Oct 14; 24(1):1154. PMID: 39396938.

     Read At: PubMed
  • Published on 10/1/2024

    Chatterjee A, Stewart EA, Assoumou SA, Chrysanthopoulou SA, Zwick H, Harris RA, O'Dea R, Schackman BR, White LF, Linas BP. Health and Economic Outcomes of Offering Buprenorphine in Homeless Shelters in Massachusetts. JAMA Netw Open. 2024 Oct 01; 7(10):e2437233. PMID: 39412807.

     Read At: PubMed
  • Published on 8/1/2024

    Wijk M, Gausi K, Malatesta S, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. J Antimicrob Chemother. 2024 Aug 01; 79(8):2022-2030. PMID: 38985541.

     Read At: PubMed
  • Published on 7/1/2024

    Kimmel SD, Walley AY, White LF, Yan S, Grella C, Majeski A, Stein MD, Bettano A, Bernson D, Drainoni ML, Samet JH, Larochelle MR. Medication for Opioid Use Disorder After Serious Injection-Related Infections in Massachusetts. JAMA Netw Open. 2024 Jul 01; 7(7):e2421740. PMID: 39046742.

     Read At: PubMed
  • Published on 5/6/2024

    Yamkovoy K, Patil P, Dunn D, Erdman E, Bernson D, Swathi PA, Nall SK, Zhang Y, Wang J, Brinkley-Rubinstein L, LeMasters KH, White LF, Barocas JA. Using decision tree models and comprehensive statewide data to predict opioid overdoses following prison release. Ann Epidemiol. 2024 Jun; 94:81-90. PMID: 38710239.

     Read At: PubMed
  • Published on 3/13/2024

    Wang J, Bernson D, Erdman EA, Villani J, Chandler R, Kline D, White LF, Barocas JA. Intersectional inequities and longitudinal prevalence estimates of opioid use disorder in Massachusetts 2014-2020: a multi-sample capture-recapture analysis. Lancet Reg Health Am. 2024 Apr; 32:100709. PMID: 38510791.

     Read At: PubMed
  • Published on 3/1/2024

    Yamkovoy K, Self JL, Jenkins HE, Horsburgh CR, White LF. Patterns of TB transmission in the United States, 2011-2017. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):154-156. PMID: 38454181.

     Read At: PubMed
  • Published on 2/23/2024

    Bayly H, Stoddard M, Van Egeren D, Murray EJ, Raifman J, Chakravarty A, White LF. Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic. BMC Public Health. 2024 Feb 23; 24(1):595. PMID: 38395830.

     Read At: PubMed
  • Published on 2/7/2024

    Epstein RL, Buzzee B, White LF, Feld JJ, Castera L, Sterling RK, Linas BP, Taylor LE. Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus. J Viral Hepat. 2024 Jun; 31(6):277-292. PMID: 38326950.

     Read At: PubMed
  • Published on 1/1/2024

    Rodriguez CA, Horsburgh CR, Jenkins HE, White LF. Reply to 'Estimating TB survival - mind the immortal-time gap'. Int J Tuberc Lung Dis. 2024 Jan 01; 28(1):66-67. PMID: 38178287.

     Read At: PubMed

View 169 more publications:View Full Profile at BUMC

News & In the Media

View all profiles